179 related articles for article (PubMed ID: 19139982)
1. Liver transplantation and neurological side effects.
Saner FH; Nadalin S; Radtke A; Sotiropoulos GC; Kaiser GM; Paul A
Metab Brain Dis; 2009 Mar; 24(1):183-7. PubMed ID: 19139982
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play?
Sklar EM
AJNR Am J Neuroradiol; 2006 Sep; 27(8):1602-3. PubMed ID: 16971594
[No Abstract] [Full Text] [Related]
3. Neurocognitive-neurological complications of liver transplantation: a review.
Campagna F; Biancardi A; Cillo U; Gatta A; Amodio P
Metab Brain Dis; 2010 Mar; 25(1):115-24. PubMed ID: 20204483
[TBL] [Abstract][Full Text] [Related]
4. Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation.
Lué A; Martinez E; Navarro M; Laredo V; Lorente S; Jose Araiz J; Agustin Garcia-Gil F; Serrano MT
Transplantation; 2019 Aug; 103(8):e211-e215. PubMed ID: 30985573
[TBL] [Abstract][Full Text] [Related]
5. Late fulminant posterior reversible encephalopathy syndrome after liver transplant.
Heidenhain C; Puhl G; Neuhaus P
Exp Clin Transplant; 2009 Sep; 7(3):180-3. PubMed ID: 19715529
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant diabetic ketoacidosis--a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series.
Yoshida EM; Buczkowski AK; Sirrs SM; Elliott TG; Scudamore CH; Levin A; Tildesley HD; Landsberg DN
Transpl Int; 2000; 13(1):69-72. PubMed ID: 10743693
[TBL] [Abstract][Full Text] [Related]
7. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation.
Balderramo D; Prieto J; Cárdenas A; Navasa M
Transpl Int; 2011 Aug; 24(8):812-9. PubMed ID: 21649743
[TBL] [Abstract][Full Text] [Related]
8. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
9. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients.
Schmidt LE; Rasmussen A; Kirkegaard P; Dalhoff K
Transplantation; 2003 Jul; 76(2):358-63. PubMed ID: 12883193
[TBL] [Abstract][Full Text] [Related]
10. Differences in the incidence and clinical evolution of early neurotoxicity after liver transplantation based on tacrolimus formulation used in the immunosuppressive induction protocol.
Souto-Rodríguez R; Molina-Pérez E; Castroagudín JF; Fernández Pérez A; Otero-Antón E; Tomé Martínez de Rituerto S; Martínez-Castro J; Varo-Pérez E
Transplant Proc; 2014 Nov; 46(9):3117-20. PubMed ID: 25420839
[TBL] [Abstract][Full Text] [Related]
11. High Frequency of Arterial Hypertension in Patients After Liver Transplantation.
Gojowy D; Adamczak M; Dudzicz S; Gazda M; Karkoszka H; Wiecek A
Transplant Proc; 2016 Jun; 48(5):1721-4. PubMed ID: 27496479
[TBL] [Abstract][Full Text] [Related]
12. Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
Berenguer M; Aguilera V; San Juan F; Benlloch S; Rubin A; López-Andujar R; Moya A; Pareja E; Montalva E; Yago M; de Juan M; Mir J; Prieto M
Transplantation; 2010 Dec; 90(11):1204-9. PubMed ID: 21068701
[TBL] [Abstract][Full Text] [Related]
13. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation.
Neuberger J; Gunson B; Hubscher S; Nightingale P
Liver Transpl; 2004 Apr; 10(4):488-91. PubMed ID: 15048790
[TBL] [Abstract][Full Text] [Related]
16. Calcineurin inhibitor-mediated bilateral hippocampal injury after bone marrow transplantation.
Lee SH; Kim BC; Yang DH; Park MS; Choi SM; Kim MK; Cho KH
J Neurol; 2008 Jun; 255(6):929-31. PubMed ID: 18458866
[No Abstract] [Full Text] [Related]
17. Calcineurin inhibitor-associated early renal insufficiency in cardiac transplant recipients: risk factors and strategies for prevention and treatment.
Baran DA; Galin ID; Gass AL
Am J Cardiovasc Drugs; 2004; 4(1):21-9. PubMed ID: 14967063
[TBL] [Abstract][Full Text] [Related]
18. Allergic disease after pediatric liver transplantation with systemic tacrolimus and cyclosporine a therapy.
Arikan C; Kilic M; Tokat Y; Aydogdu S
Transplant Proc; 2003 Dec; 35(8):3039-41. PubMed ID: 14697973
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus-Induced Neurotoxicity in Early Post-Liver Transplant Saudi Patients: Incidence and Risk Factors.
Alissa DA; Alkortas D; Alsebayel M; Almasuood RA; Aburas W; Altamimi T; Devol EB; Al-Jedai AH
Ann Transplant; 2022 May; 27():e935938. PubMed ID: 35578566
[TBL] [Abstract][Full Text] [Related]
20. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
Tönshoff B; Höcker B
Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
